Los Angeles

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• Chronic lymphocytic leukaemia1 trial
• Colorectal cancer1 trial

Phase

• Phase 1/21 trial
• Phase 31 trial

Status

• Active, not recruiting2 trials

Lead sponsor

• Bristol-Myers Squibb1 trial
• Juno Therapeutics, a Subsidiary of Celgene1 trial

Running trials

• Active, not recruiting

  A Study of Nivolumab, Nivolumab Plus Ipilimumab, or Investigator's Choice Chemotherapy for the Treatment of Participants With Deficient Mismatch Repair (dMMR)/Microsatellite Instability High (MSI-H) Metastatic Colorectal Cancer (mCRC)

  NCT04008030· Phase 3· Bristol-Myers Squibb· Source

• Active, not recruiting

  Study Evaluating Safety and Efficacy of JCAR017 in Subjects With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL)

  NCT03331198· Phase 1/2· Juno Therapeutics, a Subsidiary of Celgene· Source